I
Power Law company profile
Illumina
Biotech & Life Sciences · San Diego, United States · Founded 1998 · IPO 2000 Decacorn
Valuation
$19B
Market cap · Apr/2026
Revenue
$4.34B
Latest reported FY
Global footprint
Where Illumina has talent and traffic
AI talent share
1.0%
of workforce is AI talent
(92 of 9,578 staff)
(92 of 9,578 staff)
Core AI520.54%
Other AI400.42%
Non-AI workforce9,48699.04%
Web traffic by country
770K
monthly visits
across markets
across markets
🇺🇸 United States40.4%
🇬🇧 United Kingdom6%
🇯🇵 Japan5.4%
🇧🇷 Brazil2.6%
🇨🇦 Canada2.6%
Patent intelligence
$2.7B patent portfolio · 2,241 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$2.7B
14.2% of market cap · 4.4× the top peer BGI ($627M)
2,241 active patent families
Where Illumina innovates
BioinformaticsMolecular biologyNucleic acidNucleotideComputational biology
Above peer median on Market
Quality vs same-sector peers
Illumina on the five Patsnap quality dimensions
Illumina in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Illumina concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Illumina and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Illumina on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.